Systematic review will examine how short-form video platforms frame ADHD and autism

Short-form video has become one of the main places where young adults encounter mental health information, and ADHD and autism spectrum disorder are now among the most visible topics in that feed. The new protocol is built around a basic but clinically consequential question: when popular clips explain neurodiversity, how much of what viewers absorb is accurate, guideline-consistent, and potentially helpful rather than misleading?

The concern is not abstract. Social media now functions as a first-pass information source for many people, including users who may be wondering whether everyday distractibility, social difficulty, or emotional overwhelm reflects a diagnosable condition. In that setting, fast, highly shareable content can compress complex clinical syndromes into simple narratives, personality labels, or diagnostic checklists. Those shortcuts may increase awareness, but they can also distort symptom perception, reinforce stigma, or encourage self-diagnosis without proper evaluation.

This protocol, published in PLOS One with DOI 10.1371/journal.pone.0357837, is positioned to address a gap that has been easy to recognize and harder to quantify. No prior synthesis has pulled together the literature on the scientific accuracy of short-form video content about ADHD and ASD, or on the downstream effects of that content on viewers. The planned review aims to move beyond anecdote and ask what the evidence actually shows about what people are watching, what messages are being repeated, and what those messages do.

What the review will measure in ADHD and autism video content

The protocol sets out three clear objectives. First, it will describe the popularity and characteristics of ADHD and ASD short-form video content. Second, it will evaluate whether the content follows clinical guidelines. Third, it will examine the effects on stigma, treatment-seeking, diagnosis-seeking, and symptom perceptions.

Those outcomes matter because short-form videos compress clinical information into a format optimized for attention, not accuracy. A clip that presents a checklist of traits as proof of autism or ADHD can blur the line between legitimate symptom education and oversimplified identity labeling. In clinical practice, that distinction affects who seeks care, how patients understand themselves, and whether they arrive with realistic expectations about diagnosis and treatment.

The review is designed to capture the literature from multiple angles. It will include qualitative, quantitative, and mixed-methods peer-reviewed studies published in English by June 1, 2026. Search activity will span PsycINFO, PubMed, and SCOPUS, which should give the project reach across psychiatry, psychology, communication science, and related fields. Once duplicates are removed, pairs of independent reviewers will screen titles and abstracts, then assess full texts for eligibility.

Independent screening reduces the chance that a highly visible but methodologically weak study slips through simply because it is popular or easy to find. The protocol also follows the 2020 PRISMA-P framework, which provides structure for transparent systematic review planning before results are known.

Why misinformation on neurodiversity content can change bedside behavior

A single video rarely causes a diagnosis, but repeated exposure can shape how symptoms are interpreted long before a patient reaches a clinic. If a viewer repeatedly sees ADHD framed as chronic impulsivity and autism framed only through social awkwardness or sensory traits, the resulting mental model may be shallow and incomplete. That can influence whether someone seeks assessment, delays care, or assumes a self-label is sufficient without formal evaluation.

The clinical stakes are real. For some viewers, social media content may lower the threshold for recognizing a pattern that truly deserves professional attention. For others, the same content may normalize everyday behaviors as disorder, intensify anxiety about normal variation, or encourage treatment expectations that do not match evidence-based care. The protocol explicitly recognizes this tension by including impacts on stigma and both treatment- and diagnosis-seeking, not just content accuracy alone.

What makes the project especially relevant is the format itself. Short-form video rewards speed, emotional punch, and algorithmic reach. Those features can amplify compelling stories about neurodivergence, but they also reward simplification, identity branding, and repeatable claims that may not hold up under clinical scrutiny. A platform built for virality is not naturally built for nuance.

A review protocol built for descriptive and thematic synthesis

The planned analysis will use both descriptive and thematic methods. Descriptive analysis should help define how often certain themes appear, what characteristics dominate the content, and how closely the material aligns with established clinical guidance. Thematic analysis, by contrast, should help map the deeper patterns in how creators present symptoms, frame identity, and influence viewer behavior.

This dual approach is appropriate for a topic where the question is not only whether information is correct, but also how it is packaged and received. A video can be factually incomplete and still persuasive. It can also be clinically sloppy while appearing reassuring. Thematic analysis offers a way to capture those patterns rather than flatten them into yes-or-no accuracy scores.

The planned registration with Open Science Framework Registries adds another layer of transparency. Protocol registration matters here because it reduces the risk of post hoc changes to inclusion criteria or analytic priorities once the literature has been seen. For a subject as socially charged as autism and ADHD content online, methodological discipline will be essential.

The unanswered question is what social media is doing to symptom perception

The protocol does not claim results, and it should not. Its value lies in setting up a systematic look at a question that affects patients, families, and clinicians every day: how much of the neurodiversity content circulating on short-form video platforms is scientifically grounded, and how much is shaping beliefs in ways that clinical care will later have to correct?

A useful review could do more than identify misinformation. It could clarify which content patterns appear most often, which messages are most likely to travel, and where mental health professionals may need to intervene with better public education. For now, the most important contribution is the framework itself: a structured plan to measure a digital phenomenon that has already entered the exam room, the waiting room, and the self-diagnosis process long before formal evidence has caught up.

Until the review is completed, the field is left with an important limitation: visibility is not the same as validity, and popularity is not the same as clinical accuracy. This protocol is designed to test how wide that gap may be.


Reporting by Dr. A. Manasa, MBBS for Medicine World Foundation, with additional data provided by PLOS Medicine.
PRIMARY CLINICAL EVIDENCE & REGISTRY DATA